30
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Neuroinflammation and autism: what have we learned so far?

ORCID Icon & ORCID Icon
Received 12 Dec 2023, Accepted 07 Jun 2024, Published online: 20 Jun 2024

References

  • Abdallah, M. W., N. Larsen, E. L. Mortensen, H. Ó. Atladóttir, B. Nørgaard-Pedersen, E. C. Bonefeld-Jørgensen, J. Grove, and D. M. Hougaard. 2012. “Neonatal Levels of Cytokines and Risk of Autism Spectrum Disorders: An Exploratory Register-Based Historic Birth Cohort Study Utilizing the Danish Newborn Screening Biobank.” Journal of Neuroimmunology 252 (12): 75–82. https://doi.org/10.1016/j.jneuroim.2012.07.013.
  • Adams-Chapman, I., and B. J. Stoll. 2006. “Neonatal Infection and Long-Term Neurodevelopmental Outcome in the Preterm Infant.” Current Opinion in Infectious Diseases 19 (3): 290–297. https://doi.org/10.1097/01.qco.0000224825.57976.87.
  • Ahmad, S. F., A. Nadeem, M. A. Ansari, S. A. Bakheet, S. M. Attia, K. M. A. Zoheir, L. Y. Al-Ayadhi, et al. 2017a. “Imbalance between the anti- and Pro-Inflammatory Milieu in Blood Leukocytes of Autistic Children.” Molecular Immunology 82: 57–65. https://doi.org/10.1016/j.molimm.2016.12.019.
  • Ahmad, S. F., K. M. A. Zoheir, M. A. Ansari, A. Nadeem, S. A. Bakheet, L. Y. Al-Ayadhi, M. Z. Alzahrani, O. A. Al-Shabanah, M. M. Al-Harbi, and S. M. Attia. 2017b. “Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in Children with Autism.” Molecular Neurobiology 54 (6): 4390–4400. https://doi.org/10.1007/s12035-016-9977-0.
  • Al-Ayadhi, Y. L., and A. G. Mostafa. 2012. “Elevated Serum Levels of Interleukin-17A in Children with Autism.” Journal of Neuroinflammation 9 (1): 158. https://doi.org/10.1186/1742-2094-9-158.
  • Aldossari, A. A., M. A. Ansari, A. Nadeem, S. M. Attia, S. A. Bakheet, L. Y. Al-Ayadhi, M. M. Alanazi, et al. 2023. “Upregulation of Inflammatory Mediators in Peripheral Blood CD40+ Cells in Children with Autism Spectrum Disorder.” International Journal of Molecular Sciences 24 (8): 7475. https://doi.org/10.3390/ijms24087475.
  • Alessio, N., A. L. Brigida, G. Peluso, N. Antonucci, U. Galderisi, and D. Siniscalco. 2020. “Stem Cell-Derived Exosomes in Autism Spectrum Disorder.” International Journal of Environmental Research and Public Health 17 (3): 944. https://doi.org/10.3390/ijerph17030944.
  • American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association.
  • Anderson, G. M., A. Jacobs-Stannard, K. Chawarska, F. R. Volkmar, and H. J. Kliman. 2007. “Placental Trophoblast Inclusions in Autism Spectrum Disorder.” Biological Psychiatry 61 (4): 487–491. https://doi.org/10.1016/j.biopsych.2006.03.068.
  • Ashwood, P., A. Enstrom, P. Krakowiak, I. Hertz-Picciotto, R. L. Hansen, L. A. Croen, S. Ozonoff, I. N. Pessah, and J. Van de Water. 2008a. “Decreased Transforming Growth Factor beta1 in Autism: A Potential Link between Immune Dysregulation and Impairment in Clinical Behavioral Outcomes.” Journal of Neuroimmunology 204 (1–2): 149–153. https://doi.org/10.1016/j.jneuroim.2008.07.006.
  • Ashwood, P., A. Enstrom, C. Onore, I. Hertz-Picciotto, R. Hansen, L. Croen, and J. Van De Water. 2008b. “Detection of IL-17 and IL-23 in Plasma Samples of Children with Autism.” American Journal of Biochemistry & Biotechnology 4 (2): 114–120. https://doi.org/10.3844/ajbbsp.2008.114.120.
  • Ashwood, P., P. Krakowiak, I. Hertz-Picciotto, R. Hansen, I. Pessah, and J. Van de Water. 2011a. “Elevated Plasma Cytokines in Autism Spectrum Disorders Provide Evidence of Immune Dysfunction and Are Associated with Impaired Behavioral Outcome.” Brain, Behavior, and Immunity 25 (1): 40–45. https://doi.org/10.1016/j.bbi.2010.08.003.
  • Ashwood, P., P. Krakowiak, I. Hertz-Picciotto, R. Hansen, I. N. Pessah, and J. Van de Water. 2011b. “Associations of Impaired Behaviors with Elevated Plasma Chemokines in Autism Spectrum Disorders.” Journal of Neuroimmunology 232 (1–2): 196–199. https://doi.org/10.1016/j.jneuroim.2010.10.025.
  • Ashwood, P., and A. J. Wakefield. 2006. “Immune Activation of Peripheral Blood and Mucosal CD3+ Lymphocyte Cytokine Profiles in Children with Autism and Gastrointestinal Symptoms.” Journal of Neuroimmunology 173 (12): 126–134. https://doi.org/10.1016/j.jneuroim.2005.12.007.
  • Atladóttir, H. Ó., P. Thorsen, L. Østergaard, D. E. Schendel, S. Lemcke, M. Abdallah, and E. T. Parner. 2010. “Maternal Infection Requiring Hospitalization during Pregnancy and Autism Spectrum Disorders.” Journal of Autism and Developmental Disorders 40 (12): 1423–1430. https://doi.org/10.1007/s10803-010-1006-y.
  • Auerbach, B. D., E. K. Osterweil, and M. F. Bear. 2011. “Mutations Causing Syndromic Autism Define an Axis of Synaptic Pathophysiology.” Nature 480 (7375): 63–68. https://doi.org/10.1038/nature10658.
  • Bagnall-Moreau, C., B. Spielman, and L. Brimberg. 2023. “Maternal Brain Reactive Antibodies Profile in Autism Spectrum Disorder: An Update.” Translational Psychiatry 13 (1): 37. https://doi.org/10.1038/s41398-023-02335-3.
  • Basheer, S., M. M. Venkataswamy, R. Christopher, T. Van Amelsvoort, S. Srinath, S. C. Girimaji, and V. Ravi. 2018. “Immune Aberrations in Children with Autism Spectrum Disorder: A Case-Control Study from a Tertiary Care Neuropsychiatric Hospital in India.” Psychoneuroendocrinology 94: 162–167. https://doi.org/10.1016/j.psyneuen.2018.05.002.
  • Berry-Kravis, E., J. P. Horrigan, N. Tartaglia, R. Hagerman, A. Kolevzon, C. A. Erickson, S. Hatti, et al. 2020. “A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome.” Pediatric Neurology 110: 30–41. https://doi.org/10.1016/j.pediatrneurol.2020.04.019.
  • Bettelli, E., V. K. Kuchroo, and M. Oukka. 2007. “T H-17 Cells in the Circle of Immunity and Autoimmunity.” Nature Immunology 8 (4): 345–350. https://doi.org/10.1038/ni0407-345.
  • Boche, D., V. H. Perry, and J. A. R. Nicoll. 2013. “Review: Activation Patterns of Microglia and Their Identification in the Human Brain.” Neuropathology and Applied Neurobiology 39 (1): 3–18. https://doi.org/10.1111/nan.12011.
  • Borges, F. T., L. A. Reis, and N. Schor. 2013. “Extracellular Vesicles: Structure, Function, and Potential Clinical Uses in Renal Diseases.” Brazilian Journal of Medical and Biological Research 46 (10): 824–830. https://doi.org/10.1590/1414-431X20132964.
  • Bourgeron, T. 2015. “From the Genetic Architecture to Synaptic Plasticity in Autism Spectrum Disorder.” Nature Reviews Neuroscience 16 (9): 551–563. https://doi.org/10.1038/nrn3992.
  • Braunschweig, D., and J. Van De Water. 2012. “Maternal Autoantibodies in Autism.” Archives of Neurology 69 (6): 693–699. https://doi.org/10.1001/archneurol.2011.2506.
  • Brimberg, L., A. Sadiq, P. K. Gregersen, and B. Diamond. 2013. “Brain-Reactive IgG Correlates with Autoimmunity in Mothers of a Child with an Autism Spectrum Disorder.” Molecular Psychiatry 18 (11): 1171–1177. https://doi.org/10.1038/mp.2013.101.
  • Broek, J. A. C., P. C. Guest, H. Rahmoune, and S. Bahn. 2014. “Proteomic Analysis of Post Mortem Brain Tissue from Autism Patients: Evidence for opposite Changes in Prefrontal Cortex and Cerebellum in Synaptic Connectivity-Related Proteins.” Molecular Autism 5 (1): 41. https://doi.org/10.1186/2040-2392-5-41.
  • Buc, M. 2013. “Role of Regulatory T Cells in Pathogenesis and Biological Therapy of Multiple Sclerosis.” Mediators of Inflammation 2013: 963748. https://doi.org/10.1155/2013/963748.
  • Byles, V., A. J. Covarrubias, I. Ben-Sahra, D. W. Lamming, D. M. Sabatini, B. D. Manning, and T. Horng. 2013. “The TSC-mTOR Pathway Regulates Macrophage Polarization.” Nature Communications 4 (1): 2834. https://doi.org/10.1038/ncomms3834.
  • Cao, X., K. Liu, J. Liu, Y. W. Liu, L. Xu, H. Wang, Y. Zhu, et al. 2021. “Dysbiotic Gut Microbiota and Dysregulation of Cytokine Profile in Children and Teens with Autism Spectrum Disorder.” Frontiers in Neuroscience 15: 635925. https://doi.org/10.3389/fnins.2021.635925.
  • Careaga, M., S. Rogers, R. L. Hansen, D. G. Amaral, J. Van de Water, and P. Ashwood. 2017. “Immune Endophenotypes in Children with Autism Spectrum Disorder.” Biological Psychiatry 81 (5): 434–441. https://doi.org/10.1016/j.biopsych.2015.08.036.
  • Carpentier, P. A., and T. D. Palmer. 2009. “Immune Influence on Adult Neural Stem Cell Regulation and Function.” Neuron 64 (1): 79–92. https://doi.org/10.1016/j.neuron.2009.08.038.
  • Casanova, M. F., I. A. J. van Kooten, A. E. Switala, H. van Engeland, H. Heinsen, H. W. M. Steinbusch, P. R. Hof, J. Trippe, J. Stone, and C. Schmitz. 2006. “Minicolumnar Abnormalities in Autism.” Acta Neuropathologica 112 (3): 287–303. https://doi.org/10.1007/s00401-006-0085-5.
  • Chana, G., L. Laskaris, C. Pantelis, P. Gillett, R. Testa, D. Zantomio, E. L. Burrows, A. J. Hannan, I. P. Everall, and E. Skafidas. 2015. “Decreased Expression of mGluR5 within the Dorsolateral Prefrontal Cortex in Autism and Increased Microglial Number in mGluR5 Knockout Mice: Pathophysiological and Neurobehavioral Implications.” Brain, Behavior, and Immunity 49: 197–205. https://doi.org/10.1016/j.bbi.2015.05.009.
  • Chen, B. Y., X. Wang, Z. Y. Wang, Y. Z. Wang, L. W. Chen, and Z. J. Luo. 2013. “Brain-Derived Neurotrophic Factor Stimulates Proliferation and Differentiation of Neural Stem Cells, Possibly by Triggering the Wnt/β-Catenin Signaling Pathway.” Journal of Neuroscience Research 91 (1): 30–41. https://doi.org/10.1002/jnr.23138.
  • Chen, W., Y. Huang, J. Han, L. Yu, Y. Li, Z. Lu, H. Li, et al. 2016. “Immunomodulatory Effects of Mesenchymal Stromal Cells-Derived Exosome.” Immunologic Research 64 (4): 831–840. https://doi.org/10.1007/s12026-016-8798-6.
  • Chez, M. G., T. Dowling, P. B. Patel, P. Khanna, and M. Kominsky. 2007. “Elevation of Tumor Necrosis Factor-Alpha in Cerebrospinal Fluid of Autistic Children.” Pediatric Neurology 36 (6): 361–365. https://doi.org/10.1016/j.pediatrneurol.2007.01.012.
  • Choi, G. B., Y. S. Yim, H. Wong, S. Kim, H. Kim, S. V. Kim, C. A. Hoeffer, D. R. Littman, and J. R. Huh. 2016. “The Maternal Interleukin-17a Pathway in Mice Promotes Autism-like Phenotypes in Offspring.” Science (New York, N.Y.) 351 (6276): 933–939. https://doi.org/10.1126/science.aad0314.
  • Cianciulli, A., C. Porro, R. Calvello, T. Trotta, D. D. Lofrumento, and M. A. Panaro. 2020. “Microglia Mediated Neuroinflammation: Focus on PI3K Modulation.” Biomolecules 10 (1): 137. https://doi.org/10.3390/biom10010137.
  • Ciurkiewicz, M., V. Herder, and A. Beineke. 2020. “Beneficial and Detrimental Effects of Regulatory T Cells in Neurotropic Virus Infections.” International Journal of Molecular Sciences 21 (5): 1705. https://doi.org/10.3390/ijms21051705.
  • Cohen, D., N. Pichard, S. Tordjman, C. Baumann, L. Burglen, E. Excoffier, G. Lazar, et al. 2005. “Specific Genetic Disorders and Autism: Clinical Contribution towards Their Identification.” Journal of Autism and Developmental Disorders 35 (1): 103–116. https://doi.org/10.1007/s10803-004-1038-2.
  • Coury, D. L., P. Ashwood, A. Fasano, G. Fuchs, M. Geraghty, A. Kaul, G. Mawe, P. Patterson, and N. E. Jones. 2012. “Gastrointestinal Conditions in Children with Autism Spectrum Disorder: Developing a Research Agenda.” Pediatrics 130(Suppl.2): S160–S168. https://doi.org/10.1542/peds.2012-0900N.
  • Cowan, C. S. M., T. G. Dinan, and J. F. Cryan. 2020. “Annual Research Review: Critical Windows – The Microbiota–Gut–Brain Axis in Neurocognitive Development.” Journal of Child Psychology and Psychiatry 61 (3): 353–371. https://doi.org/10.1111/jcpp.13156.
  • Critchfield, J. W., S. Van Hemert, M. Ash, L. Mulder, and P. Ashwood. 2011. “The Potential Role of Probiotics in the Management of Childhood Autism Spectrum Disorders.” Gastroenterology Research and Practice 2011: 161358. https://doi.org/10.1155/2011/161358.
  • Croen, L. A., P. Goines, D. Braunschweig, R. Yolken, C. K. Yoshida, J. K. Grether, B. Fireman, M. Kharrazi, R. L. Hansen, and J. Van De Water. 2008. “Brain-Derived Neurotrophic Factor and Autism: Maternal and Infant Peripheral Blood Levels in the Early Markers for Autism (EMA) Study.” Autism Research 1 (2): 130–137. https://doi.org/10.1002/aur.14.
  • Croen, L. A., O. Zerbo, Y. Qian, M. L. Massolo, S. Rich, S. Sidney, and C. Kripke. 2015. “The Health Status of Adults on the Autism Spectrum.” Autism 19 (7): 814–823. https://doi.org/10.1177/1362361315577517.
  • Croonenberghs, J., E. Bosmans, D. Deboutte, G. Kenis, and M. Maes. 2002. “Biological Psychiatry Activation of the Inflammatory Response System in Autism.” Neuropsychobiology 45 (1): 1–6. https://doi.org/10.1159/000048665.
  • Cunningham, C. L., V. Martínez-Cerdeño, and S. C. Noctor. 2013. “Microglia Regulate the Number of Neural Precursor Cells in the Developing Cerebral Cortex.” Journal of Neuroscience 33 (10): 4216–4233.
  • Dalton, P., R. Deacon, A. Blamire, M. Pike, I. McKinlay, J. Stein, P. Styles, and A. Vincent. 2003. “Maternal Neuronal Antibodies Associated with Autism and a Language Disorder.” Annals of Neurology 53 (4): 533–537. https://doi.org/10.1002/ana.10557.
  • Dan, H. C., M. J. Cooper, P. C. Cogswell, J. A. Duncan, J. P. Y. Ting, and A. S. Baldwin. 2008. “Akt-Dependent Regulation of NF-κB is Controlled by mTOR and Raptor in Association with IKK.” Genes & Development 22 (11): 1490–1500. https://doi.org/10.1101/gad.1662308.
  • Dasgupta, S., S. Dasgupta, and M. Bandyopadhyay. 2020. “Regulatory B Cells in Infection, Inflammation, and Autoimmunity.” Cellular Immunology 352: 104076. https://doi.org/10.1016/j.cellimm.2020.104076.
  • Derecki, N. C., A. N. Cardani, C. H. Yang, K. M. Quinnies, A. Crihfield, K. R. Lynch, and J. Kipnis. 2010. “Regulation of Learning and Memory by Meningeal Immunity: A Key Role for IL-4.” Journal of Experimental Medicine 207 (5): 1067–1080. https://doi.org/10.1084/jem.20091419.
  • Deverman, B. E., and P. H. Patterson. 2009. “Cytokines and CNS Development.” Neuron 64 (1): 61–78. https://doi.org/10.1016/j.neuron.2009.09.002.
  • Dey, A., X. Kang, J. Qiu, Y. Du, and J. Jiang. 2016. “Anti-Inflammatory Small Molecules to Treat Seizures and Epilepsy: From Bench to Bedside.” Trends in Pharmacological Sciences 37 (6): 463–484. https://doi.org/10.1016/j.tips.2016.03.001.
  • DiStasio, M. M., I. Nagakura, M. J. Nadler, and M. P. Anderson. 2019. “T Lymphocytes and Cytotoxic Astrocyte Blebs Correlate across Autism Brains.” Annals of Neurology 86 (6): 885–898. https://doi.org/10.1002/ana.25610.
  • Edmonson, C., M. N. Ziats, and O. M. Rennert. 2014. “Altered Glial Marker Expression in Autistic Post-Mortem Prefrontal Cortex and Cerebellum.” Molecular Autism 5 (1): 3. https://doi.org/10.1186/2040-2392-5-3.
  • Ehninger, D., and A. J. Silva. 2011. “Rapamycin for Treating Tuberous Sclerosis and Autism Spectrum Disorders.” Trends in Molecular Medicine 17 (2): 78–87. https://doi.org/10.1016/j.molmed.2010.10.002.
  • Ellul, P., M. Rosenzwajg, H. Peyre, G. Fourcade, E. Mariotti-Ferrandiz, V. Trebossen, D. Klatzmann, and R. Delorme. 2021. “Regulatory T Lymphocytes/Th17 Lymphocytes Imbalance in Autism Spectrum Disorders: Evidence from a Meta-Analysis.” Molecular Autism 12 (1): 68. https://doi.org/10.1186/s13229-021-00472-4.
  • Enstrom, A. M., C. E. Onore, J. A. Van de Water, and P. Ashwood. 2010. “Differential Monocyte Responses to TLR Ligands in Children with Autism Spectrum Disorders.” Brain, Behavior, and Immunity 24 (1): 64–71. https://doi.org/10.1016/j.bbi.2009.08.001.
  • Fattorusso, A., L. Di Genova, G. B. Dell’Isola, E. Mencaroni, and S. Esposito. 2019. “Autism Spectrum Disorders and the Gut Microbiota.” Nutrients 11 (3): 521. https://doi.org/10.3390/nu11030521.
  • Felger, J. C., and F. E. Lotrich. 2013. “Inflammatory Cytokines in Depression: Neurobiological Mechanisms and Therapeutic Implications.” Neuroscience 246: 199–229. https://doi.org/10.1016/j.neuroscience.2013.04.060.
  • Finegold, S. M. 2011. “State of the Art; Microbiology in Health and Disease. Intestinal Bacterial Flora in Autism.” Anaerobe 17 (6): 367–368. https://doi.org/10.1016/j.anaerobe.2011.03.007.
  • Fiorentino, M., A. Sapone, S. Senger, S. S. Camhi, S. M. Kadzielski, T. M. Buie, D. L. Kelly, N. Cascella, and A. Fasano. 2016. “Blood-Brain Barrier and Intestinal Epithelial Barrier Alterations in Autism Spectrum Disorders.” Molecular Autism 7 (1): 49. https://doi.org/10.1186/s13229-016-0110-z.
  • Fortier, M. È., R. Joober, G. N. Luheshi, and P. Boksa. 2004. “Maternal Exposure to Bacterial Endotoxin during Pregnancy Enhances Amphetamine-Induced Locomotion and Startle Responses in Adult Rat Offspring.” Journal of Psychiatric Research 38 (3): 335–345. https://doi.org/10.1016/j.jpsychires.2003.10.001.
  • Galeotti, C., S. V. Kaveri, and J. Bayry. 2017. “IVIG-Mediated Effector Functions in Autoimmune and Inflammatory Diseases.” International Immunology 29 (11): 491–498. https://doi.org/10.1093/intimm/dxx039.
  • Garbett, K., P. J. Ebert, A. Mitchell, C. Lintas, B. Manzi, K. Mirnics, and A. M. Persico. 2008. “Immune Transcriptome Alterations in the Temporal Cortex of Subjects with Autism.” Neurobiology of Disease 30 (3): 303–311. https://doi.org/10.1016/j.nbd.2008.01.012.
  • Glasson, E. J., C. Bower, B. Petterson, N. de Klerk, G. Chaney, and J. F. Hallmayer. 2004. “Perinatal Factors and the Development of Autism a Population Study.” Archives of General Psychiatry 61 (6): 618–627. https://doi.org/10.1001/archpsyc.61.6.618.
  • Goines, P., and J. Van De Water. 2010. “The Immune System’s Role in the Biology of Autism.” Current Opinion in Neurology 23 (2): 111–117. https://doi.org/10.1097/WCO.0b013e3283373514.
  • Gottfried, C., V. Bambini-Junior, F. Francis, R. Riesgo, and W. Savino. 2015. “The Impact of Neuroimmune Alterations in Autism Spectrum Disorder.” Frontiers in Psychiatry 6 (Sep): 121. https://doi.org/10.3389/fpsyt.2015.00121.
  • Graves, D. T., and Y. Jiang. 1995. “Chemokines, A Family of Chemotactic Cytokines.” Critical Reviews in Oral Biology and Medicine 6 (2): 109–118. https://doi.org/10.1177/10454411950060020101.
  • Gupta, S., S. Aggarwal, B. Rashanravan, and T. Lee. 1998. “Th1-and Th2-like Cytokines in CD4 q and CD8 q T Cells in Autism.” Journal of Neuroimmunology 85 (1): 106–109. https://doi.org/10.1016/s0165-5728(98)00021-6.
  • Han, V. X., S. Patel, H. F. Jones, T. C. Nielsen, S. S. Mohammad, M. J. Hofer, W. Gold, et al. 2021. “Maternal Acute and Chronic Inflammation in Pregnancy is Associated with Common Neurodevelopmental Disorders: A Systematic Review.” Translational Psychiatry 11 (1): 71. https://doi.org/10.1038/s41398-021-01198-w.
  • Han, Y. M. Y., S. Y. Yau, M. M. Y. Chan, C. K. Wong, and A. S. Chan. 2022. “Altered Cytokine and BDNF Levels in Individuals with Autism Spectrum Disorders.” Brain Sciences 12 (4): 460. https://doi.org/10.3390/brainsci12040460.
  • Harry, G. J., and A. D. Kraft. 2012. “Microglia in the Developing Brain: A Potential Target with Lifetime Effects.” NeuroToxicology 33 (2): 191–206. https://doi.org/10.1016/j.neuro.2012.01.012.
  • He, F., W. Ge, K. Martinowich, S. Becker-Catania, V. Coskun, W. Zhu, H. Wu, et al. 2005. “A Positive Autoregulatory Loop of Jak-STAT Signaling Controls the Onset of Astrogliogenesis.” Nature Neuroscience 8 (5): 616–625. https://doi.org/10.1038/nn1440.
  • Heo, J. S., Y. Choi, H. O. Kim, and C. Matta. 2019. “Adipose-Derived Mesenchymal Stem Cells Promote M2 Macrophage Phenotype through Exosomes.” Stem Cells International 2019: 7921760. https://doi.org/10.1155/2019/7921760.
  • Heo, Y., Y. Zhang, D. Gao, V. M. Miller, and D. A. Lawrence. 2011. “Aberrant Immune Responses in a Mouse with Behavioral Disorders.” PLoS One 6 (7): e20912. https://doi.org/10.1371/journal.pone.0020912.
  • Hsiao, E. Y., S. W. McBride, J. Chow, S. K. Mazmanian, and P. H. Patterson. 2012. “Modeling an Autism Risk Factor in Mice Leads to Permanent Immune Dysregulation.” Proceedings of the National Academy of Sciences of the United States of America 109 (31): 12776–12781. https://doi.org/10.1073/pnas.1202556109.
  • Hu, C. C., X. Xu, G. L. Xiong, Q. Xu, B. R. Zhou, C. Y. Li, Q. Qin, et al. 2018. “Alterations in Plasma Cytokine Levels in Chinese Children with Autism Spectrum Disorder.” Autism Research 11 (7): 989–999. https://doi.org/10.1002/aur.1940.
  • Hu, V. W., A. T. Nguyen, K. S. Kim, M. E. Steinberg, T. Sarachana, M. A. Scully, S. J. Soldin, T. Luu, and N. H. Lee. 2009. “Gene Expression Profiling of Lymphoblasts from Autistic and Nonaffected Sib Pairs: Altered Pathways in Neuronal Development and Steroid Biosynthesis.” PLoS One 4 (6): e5775. https://doi.org/10.1371/journal.pone.0005775.
  • Hughes, H. K., E. Mills Ko, D. Rose, and P. Ashwood. 2018. “Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders.” Frontiers in Cellular Neuroscience 12: 405. https://doi.org/10.3389/fncel.2018.00405.
  • Hutsler, J. J., and H. Zhang. 2010. “Increased Dendritic Spine Densities on Cortical Projection Neurons in Autism Spectrum Disorders.” Brain Research 1309: 83–94. https://doi.org/10.1016/j.brainres.2009.09.120.
  • Jin, Y., L. H. Sun, W. Yang, R. J. Cui, and S. B. Xu. 2019. “The Role of BDNF in the Neuroimmune Axis Regulation of Mood Disorders.” Frontiers in Neurology 10: 515. https://doi.org/10.3389/fneur.2019.00515.
  • Jyonouchi, H., L. Geng, D. L. Streck, and G. A. Toruner. 2012. “Immunological Characterization and Transcription Profiling of Peripheral Blood (PB) Monocytes in Children with Autism Spectrum Disorders (ASD) and Specific Polysaccharide Antibody Deficiency (SPAD): Case Study.” Journal of Neuroinflammation 9 (1): 4. https://doi.org/10.1186/1742-2094-9-4.
  • Jyonouchi, H., S. Sun, and H. Le. 2001. “Proinflammatory and Regulatory Cytokine Production Associated with Innate and Adaptive Immune Responses in Children with Autism Spectrum Disorders and Developmental Regression.” Journal of Neuroimmunology 120 (1–2): 170–179. https://doi.org/10.1016/s0165-5728(01)00421-0.
  • Kalavai, S., and S. Ikezu. 2021. “Neuritogenic Function of Microglia in Maternal Immune Activation and Autism Spectrum Disorders.” Neural Regeneration Research 16 (7): 1436–1437. https://doi.org/10.4103/1673-5374.301012.
  • Kalkman, H. O., and D. Feuerbach. 2017. “Microglia M2A Polarization as Potential Link between Food Allergy and Autism Spectrum Disorders.” Pharmaceuticals 10 (4): 95. https://doi.org/10.3390/ph10040095.
  • Kartalcı, G., A. Çalışkan Demir, Ş. Kartalcı, N. Üremiş, and Y. Türköz. 2022. “Evaluation of Blood Zonulin Levels, Inflammatory Processes and Neuronal Changes in Children with Autism Spectrum Disorder.” Psychiatria Danubina 34 (2): 279–287. https://doi.org/10.24869/psyd.2022.279.
  • Kazlauskas, N., M. A. de los Robinson-Agramonte, and A. M. Depino. 2015. “Neuroinflammation in Animal Models of Autism.” In Translational Approaches to Autism Apectrum Disorder, 137–153. Heidelberg: Springer International Publishing.
  • Keown, C. L., P. Shih, A. Nair, N. Peterson, M. E. Mulvey, and R. A. Müller. 2013. “Local Functional Overconnectivity in Posterior Brain Regions is Associated with Symptom Severity in Autism Spectrum Disorders.” Cell Reports 5 (3): 567–572. https://doi.org/10.1016/j.celrep.2013.10.003.
  • Kern, J. K., D. A. Geier, L. K. Sykes, M. R. Geier, and R. C. Deth. 2015. “Are ASD and ADHD a Continuum? A Comparison of Pathophysiological Similarities between the Disorders.” Journal of Attention Disorders 19 (9): 805–827. https://doi.org/10.1177/1087054712459886.
  • Khan, D., P. Fernando, A. Cicvaric, A. Berger, A. Pollak, F. J. Monje, and D. D. Pollak. 2014. “Long-Term Effects of Maternal Immune Activation on Depression-like Behavior in the Mouse.” Translational Psychiatry 4 (2): e363. https://doi.org/10.1038/tp.2013.132.
  • Khwaja, O. S., E. Ho, K. V. Barnes, H. M. O'Leary, L. M. Pereira, Y. Finkelstein, C. A. Nelson, et al. 2014. “Safety, Pharmacokinetics, and Preliminary Assessment of Efficacy of Mecasermin (Recombinant Human IGF-1) for the Treatment of Rett Syndrome.” Proceedings of the National Academy of Sciences of the United States of America 111 (12): 4596–4601. https://doi.org/10.1073/pnas.1311141111.
  • Kim, J. W., J. Y. Hong, and S. M. Bae. 2018. “Microglia and Autism Spectrum Disorder: Overview of Current Evidence and Novel Immunomodulatory Treatment Options.” Clinical Psychopharmacology and Neuroscience 16 (3): 246–252. https://doi.org/10.9758/cpn.2018.16.3.246.
  • Krakowiak, P., P. E. Goines, D. J. Tancredi, P. Ashwood, R. L. Hansen, I. Hertz-Picciotto, and J. Van de Water. 2017. “Neonatal Cytokine Profiles Associated with Autism Spectrum Disorder.” Biological Psychiatry 81 (5): 442–451. https://doi.org/10.1016/j.biopsych.2015.08.007.
  • Lan, R. Y., A. A. Ansari, Z. X. Lian, and M. E. Gershwin. 2005. “Regulatory T Cells: Development, Function and Role in Autoimmunity.” Autoimmunity Reviews 4 (6): 351–363. https://doi.org/10.1016/j.autrev.2005.01.007.
  • Laurence, J. A., and S. H. Fatemi. 2005. “Glial Fibrillary Acidic Protein is Elevated in Superior Frontal, Parietal and Cerebellar Cortices of Autistic Subjects.” Cerebellum (London, England) 4 (3): 206–210. https://doi.org/10.1080/14734220500208846.
  • Lee, A. S., E. C. Azmitia, and P. M. Whitaker-Azmitia. 2017. “Developmental Microglial Priming in Postmortem Autism Spectrum Disorder Temporal Cortex.” Brain, Behavior, and Immunity 62: 193–202. https://doi.org/10.1016/j.bbi.2017.01.019.
  • Lee, T. T., E. Skafidas, M. Dottori, D. Zantomio, C. Pantelis, I. Everall, and G. Chana. 2017. “No Preliminary Evidence of Differences in Astrocyte Density within the White Matter of the Dorsolateral Prefrontal Cortex in Autism.” Molecular Autism 8 (1): 64. https://doi.org/10.1186/s13229-017-0181-5.
  • Li, X., A. Chauhan, A. M. Sheikh, S. Patil, V. Chauhan, X. M. Li, L. Ji, T. Brown, and M. Malik. 2009. “Elevated Immune Response in the Brain of Autistic Patients.” Journal of Neuroimmunology 207 (1–2): 111–116. https://doi.org/10.1016/j.jneuroim.2008.12.002.
  • Lin, Y. T., L. S. Ro, H. L. Wang, and J. C. Chen. 2011. “Up-Regulation of Dorsal Root Ganglia BDNF and trkB Receptor in Inflammatory Pain: An in Vivo and in Vitro Study.” Journal of Neuroinflammation 8 (1): 126. https://doi.org/10.1186/1742-2094-8-126.
  • Liu, H., Z. Liang, F. Wang, C. Zhou, X. Zheng, T. Hu, X. He, X. Wu, and P. Lan. 2019. “Exosomes from Mesenchymal Stromal Cells Reduce Murine Colonic Inflammation via a Macrophage-Dependent Mechanism.” JCI Insight 4 (24): e131273. https://doi.org/10.1172/jci.insight.131273.
  • Liu, Y., D. T. Zhang, and X. G. Liu. 2015. “mTOR Signaling in T Cell Immunity and Autoimmunity.” International Reviews of Immunology 34 (1): 50–66. https://doi.org/10.3109/08830185.2014.933957.
  • London, A., M. Cohen, and M. Schwartz. 2013. “Microglia and Monocyte-Derived Macrophages: Functionally Distinct Populations That Act in Concert in CNS Plasticity and Repair.” Frontiers in Cellular Neuroscience 7: 34. https://doi.org/10.3389/fncel.2013.00034.
  • Lucchina, L., and A. M. Depino. 2014. “Altered Peripheral and Central Inflammatory Responses in a Mouse Model of Autism.” Autism Research 7 (2): 273–289. https://doi.org/10.1002/aur.1338.
  • Makinodan, M., K. Iwata, D. Ikawa, Y. Yamashita, K. Yamamuro, M. Toritsuka, S. Kimoto, et al. 2017. “Tumor Necrosis Factor-Alpha Expression in Peripheral Blood Mononuclear Cells Correlates with Early Childhood Social Interaction in Autism Spectrum Disorder.” Neurochemistry International 104: 1–5. https://doi.org/10.1016/j.neuint.2016.12.005.
  • Malkova, N. V., C. Z. Yu, E. Y. Hsiao, M. J. Moore, and P. H. Patterson. 2012. “Maternal Immune Activation Yields Offspring Displaying Mouse Versions of the Three Core Symptoms of Autism.” Brain, Behavior, and Immunity 26 (4): 607–616. https://doi.org/10.1016/j.bbi.2012.01.011.
  • Masi, A., N. Glozier, R. Dale, and A. J. Guastella. 2017. “The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder.” Neuroscience Bulletin 33 (2): 194–204. https://doi.org/10.1007/s12264-017-0103-8.
  • Masi, A., D. S. Quintana, N. Glozier, A. R. Lloyd, I. B. Hickie, and A. J. Guastella. 2015. “Cytokine Aberrations in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.” Molecular Psychiatry 20 (4): 440–446. https://doi.org/10.1038/mp.2014.59.
  • Matejuk, A., A. C. Bakke, C. Hopke, J. Dwyer, A. A. Vandenbark, and H. Offner. 2004. “Estrogen Treatment Induces a Novel Population of Regulatory Cells, Which Suppresses Experimental Autoimmune Encephalomyelitis.” Journal of Neuroscience Research 77 (1): 119–126. https://doi.org/10.1002/jnr.20145.
  • Mazmanian, S. K., H. L. Cui, A. O. Tzianabos, and D. L. Kasper. 2005. “An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System.” Cell 122 (1): 107–118. https://doi.org/10.1016/j.cell.2005.05.007.
  • McKavanagh, R., E. Buckley, and S. A. Chance. 2015. “Wider Minicolumns in Autism: A Neural Basis for Altered Processing?” Brain 138 (Pt 7): 2034–2045. https://doi.org/10.1093/brain/awv110.
  • Meltzer, A., and J. Van De Water. 2017. “The Role of the Immune System in Autism Spectrum Disorder.” Neuropsychopharmacology 42 (1): 284–298. https://doi.org/10.1038/npp.2016.158.
  • Meyer, U. 2014. “Prenatal Poly(I:C) Exposure and Other Developmental Immune Activation Models in Rodent Systems.” Biological Psychiatry 75 (4): 307–315. https://doi.org/10.1016/j.biopsych.2013.07.011.
  • Moaaz, M., S. Youssry, A. Elfatatry, and M. A. El Rahman. 2019. “Th17/Treg Cells Imbalance and Their Related Cytokines (IL-17, IL-10 and TGF-β) in Children with Autism Spectrum Disorder.” Journal of Neuroimmunology 337: 577071. https://doi.org/10.1016/j.jneuroim.2019.577071.
  • Molloy, C. A., A. L. Morrow, J. Meinzen-Derr, K. Schleifer, K. Dienger, P. Manning-Courtney, M. Altaye, and M. Wills-Karp. 2006. “Elevated Cytokine Levels in Children with Autism Spectrum Disorder.” Journal of Neuroimmunology 172 (1–2): 198–205. https://doi.org/10.1016/j.jneuroim.2005.11.007.
  • Morgan, J. T., N. Barger, D. G. Amaral, and C. M. Schumann. 2014. “Stereological Study of Amygdala Glial Populations in Adolescents and Adults with Autism Spectrum Disorder.” PLoS One 9 (10): e110356. https://doi.org/10.1371/journal.pone.0110356.
  • Mostafa, G. A., A. Al Shehab, and N. R. Fouad. 2010. “Frequency of CD4 + CD25high Regulatory T Cells in the Peripheral Blood of Egyptian Children with Autism.” Journal of Child Neurology 25 (3): 328–335. https://doi.org/10.1177/0883073809339393.
  • Naik, U. S., C. Gangadharan, K. Abbagani, B. Nagalla, N. Dasari, and S. K. Manna. 2011. “A Study of Nuclear Transcription Factor-Kappa B in Childhood Autism.” PLoS One 6 (5): e19488. https://doi.org/10.1371/journal.pone.0019488.
  • Napolioni, V., B. Ober-Reynolds, S. Szelinger, J. J. Corneveaux, T. Pawlowski, S. Ober-Reynolds, J. Kirwan, et al. 2013. “Plasma Cytokine Profiling in Sibling Pairs Discordant for Autism Spectrum Disorder.” Journal of Neuroinflammation 10 (1): 38. https://doi.org/10.1186/1742-2094-10-38.
  • Nguyen Thanh, L., H. P. Nguyen, M. D. Ngo, V. A. Bui, P. T. M. Dam, H. T. P. Bui, D. Ngo, et al. 2021. “Outcomes of Bone Marrow Mononuclear Cell Transplantation Combined with Interventional Education for Autism Spectrum Disorder.” Stem Cells Translational Medicine 10 (1): 14–26. https://doi.org/10.1002/sctm.20-0102.
  • Nickl-Jockschat, T., U. Habel, T. Maria Michel, J. Manning, A. R. Laird, P. T. Fox, F. Schneider, and S. B. Eickhoff. 2012. “Brain Structure Anomalies in Autism Spectrum Disorder-a Meta-Analysis of VBM Studies Using Anatomic Likelihood Estimation.” Human Brain Mapping 33 (6): 1470–1489. https://doi.org/10.1002/hbm.21299.
  • Nour-Eldine, W., S. M. Ltaief, N. P. Abdul Manaph, and A. R. Al-Shammari. 2022. “In Search of Immune Cellular Sources of Abnormal Cytokines in the Blood in Autism Spectrum Disorder: A Systematic Review of Case-Control Studies.” Frontiers in Immunology 13: 950275. https://doi.org/10.3389/fimmu.2022.950275.
  • Nour-Eldine, W., N. P. A. Manaph, S. M. Ltaief, N. Abdel Aati, M. H. Mansoori, S. Al Abdulla, and A. R. Al-Shammari. 2024. “Discovery of a Novel Cytokine Signature for the Diagnosis of Autism Spectrum Disorder in Young Arab Children in Qatar.” Frontiers in Psychiatry 15: 1333534. https://doi.org/10.3389/fpsyt.2024.1333534.
  • Ohja, K., E. Gozal, M. Fahnestock, L. Cai, J. Cai, J. H. Freedman, A. Switala, A. El-Baz, and G. N. Barnes. 2018. “Neuroimmunologic and Neurotrophic Interactions in Autism Spectrum Disorders: Relationship to Neuroinflammation.” Neuromolecular Medicine 20 (2): 161–173. https://doi.org/10.1007/s12017-018-8488-8.
  • Okada, K., K. Hashimoto, Y. Iwata, K. Nakamura, M. Tsujii, K. J. Tsuchiya, Y. Sekine, et al. 2007. “Decreased Serum Levels of Transforming Growth Factor-β1 in Patients with Autism.” Progress in Neuro-Psychopharmacology & Biological Psychiatry 31 (1): 187–190. https://doi.org/10.1016/j.pnpbp.2006.08.020.
  • Onore, C., A. Enstrom, P. Krakowiak, I. Hertz-Picciotto, R. Hansen, J. Van de Water, and P. Ashwood. 2009. “Decreased Cellular IL-23 but Not IL-17 Production in Children with Autism Spectrum Disorders.” Journal of Neuroimmunology 216 (12): 126–129. https://doi.org/10.1016/j.jneuroim.2009.09.005.
  • Onore, C. E., M. Careaga, B. A. Babineau, J. J. Schwartzer, R. F. Berman, and P. Ashwood. 2013. “Inflammatory Macrophage Phenotype in BTBR T + tf/J Mice.” Frontiers in Neuroscience 7: 158. https://doi.org/10.3389/fnins.2013.00158.
  • Onore, C., H. Yang, J. Van de Water, and P. Ashwood. 2017. “Dynamic Akt/mTOR Signaling in Children with Autism Spectrum Disorder.” Frontiers in Pediatrics 5: 43.
  • Oskvig, D. B., A. G. Elkahloun, K. R. Johnson, T. M. Phillips, and M. Herkenham. 2012. “Maternal Immune Activation by LPS Selectively Alters Specific Gene Expression Profiles of Interneuron Migration and Oxidative Stress in the Fetus without Triggering a Fetal Immune Response.” Brain, Behavior, and Immunity 26 (4): 623–634. https://doi.org/10.1016/j.bbi.2012.01.015.
  • Ozawa, K., K. Hashimoto, T. Kishimoto, E. Shimizu, H. Ishikura, and M. Iyo. 2006. “Immune Activation during Pregnancy in Mice Leads to Dopaminergic Hyperfunction and Cognitive Impairment in the Offspring: A Neurodevelopmental Animal Model of Schizophrenia.” Biological Psychiatry 59 (6): 546–554. https://doi.org/10.1016/j.biopsych.2005.07.031.
  • Pangrazzi, L., L. Balasco, and Y. Bozzi. 2020. “Oxidative Stress and Immune System Dysfunction in Autism Spectrum Disorders.” International Journal of Molecular Sciences 21 (9): 3293. https://doi.org/10.3390/ijms21093293.
  • Park, S. E., R. Dantzer, K. W. Kelley, and R. H. McCusker. 2011. “Central Administration of Insulin-Like Growth Factor-I Decreases Depressive-Like Behavior and Brain Cytokine Expression in Mice.” Journal of Neuroinflammation 8 (1): 12. https://doi.org/10.1186/1742-2094-8-12.
  • Pascual, M., F. Ibáñez, and C. Guerri. 2020. “Exosomes as Mediators of Neuron-Glia Communication in Neuroinflammation.” Neural Regeneration Research 15 (5): 796–801. https://doi.org/10.4103/1673-5374.268893.
  • Patel, N., A. Crider, C. D. Pandya, A. O. Ahmed, and A. Pillai. 2016. “Altered mRNA Levels of Glucocorticoid Receptor, Mineralocorticoid Receptor, and Co-Chaperones (FKBP5 and PTGES3) in the Middle Frontal Gyrus of Autism Spectrum Disorder Subjects.” Molecular Neurobiology 53 (4): 2090–2099. https://doi.org/10.1007/s12035-015-9178-2.
  • Perets, N., S. Hertz, M. London, and D. Offen. 2018. “Intranasal Administration of Exosomes Derived from Mesenchymal Stem Cells Ameliorates Autistic-like Behaviors of BTBR Mice.” Molecular Autism 9 (1): 57. https://doi.org/10.1186/s13229-018-0240-6.
  • Perkins, N. D. 2004. “NF-κB: Tumor Promoter or Suppressor?” Trends in Cell Biology 14 (2): 64–69. https://doi.org/10.1016/j.tcb.2003.12.004.
  • Powell, J. D., K. N. Pollizzi, E. B. Heikamp, and M. R. Horton. 2012. “Regulation of Immune Responses by mTOR.” Annual Review of Immunology 30 (1): 39–68. https://doi.org/10.1146/annurev-immunol-020711-075024.
  • Purcell, A. E., O. H. Jeon, A. W. Zimmerman, M. E. Blue, and J. Pevsner. 2001. “Postmortem Brain Abnormalities of the Glutamate Neurotransmitter System in Autism.” Neurology 57 (9): 1618–1628. https://doi.org/10.1212/wnl.57.9.1618.
  • Ranganath, S., and K. M. Murphy. 2001. “Structure and Specificity of GATA Proteins in Th2 Development.” Molecular and Cellular Biology 21 (8): 2716–2725. https://doi.org/10.1128/MCB.21.8.2716-2725.2001.
  • Ricci, S., R. Businaro, F. Ippoliti, V. R. Lo Vasco, F. Massoni, E. Onofri, G. M. Troili, et al. 2013. “Altered Cytokine and BDNF Levels in Autism Spectrum Disorder.” Neurotoxicity Research 24 (4): 491–501. https://doi.org/10.1007/s12640-013-9393-4.
  • Ricciardi, S., E. M. Boggio, S. Grosso, G. Lonetti, G. Forlani, G. Stefanelli, E. Calcagno, et al. 2011. “Reduced AKT/mTOR Signaling and Protein Synthesis Dysregulation in a Rett Syndrome Animal Model.” Human Molecular Genetics 20 (6): 1182–1196. https://doi.org/10.1093/hmg/ddq563.
  • Riikonen, R. 2016. “Treatment of Autistic Spectrum Disorder with Insulin-like Growth Factors.” European Journal of Paediatric Neurology 20 (6): 816–823. https://doi.org/10.1016/j.ejpn.2016.08.005.
  • Ronald, A., and R. A. Hoekstra. 2011. “Autism Spectrum Disorders and Autistic Traits: A Decade of New Twin Studies.” American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 156B (3): 255–274.
  • Rossignol, D. A., and R. E. Frye. 2021. “A Systematic Review and Meta-Analysis of Immunoglobulin g Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder.” Journal of Personalized Medicine 11 (6): 488. https://doi.org/10.3390/jpm11060488.
  • De Rubeis, S., X. He, A. P. Goldberg, C. S. Poultney, K. Samocha, A. E. Cicek, Y. Kou, et al. 2014. “Synaptic, Transcriptional and Chromatin Genes Disrupted in Autism.” Nature 515 (7526): 209–215. https://doi.org/10.1038/nature13772.
  • Safari, M. R., S. Ghafouri-Fard, R. Noroozi, A. Sayad, M. D. Omrani, A. Komaki, M. M. Eftekharian, and M. Taheri. 2017. “FOXP3 Gene Variations and Susceptibility to Autism: A Case–Control Study.” Gene 596: 119–122. https://doi.org/10.1016/j.gene.2016.10.019.
  • Saghazadeh, A., B. Ataeinia, K. Keynejad, A. Abdolalizadeh, A. Hirbod-Mobarakeh, and N. Rezaei. 2019a. “Anti-Inflammatory Cytokines in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis.” Cytokine 123: 154740. https://doi.org/10.1016/j.cyto.2019.154740.
  • Saghazadeh, A., B. Ataeinia, K. Keynejad, A. Abdolalizadeh, A. Hirbod-Mobarakeh, and N. Rezaei. 2019b. “A Meta-Analysis of Pro-Inflammatory Cytokines in Autism Spectrum Disorders: Effects of Age, Gender, and Latitude.” Journal of Psychiatric Research 115: 90–102. https://doi.org/10.1016/j.jpsychires.2019.05.019.
  • Saitoh, B.-Y., E. Tanaka, N. Yamamoto, D. van Kruining, K. Iinuma, Y. Nakamuta, H. Yamaguchi, R. Yamasaki, K. Matsumoto, and J. I. Kira. 2021. “Early Postnatal Allergic Airway Inflammation Induces Dystrophic Microglia Leading to Excitatory Postsynaptic Surplus and Autism-like Behavior.” Brain, Behavior, and Immunity 95: 362–380. https://doi.org/10.1016/j.bbi.2021.04.008.
  • Saleiro, D., and L. C. Platanias. 2015. “Intersection of mTOR and STAT Signaling in Immunity.” Trends in Immunology 36 (1): 21–29. https://doi.org/10.1016/j.it.2014.10.006.
  • Sallam, D. E., Y. S. Shaker, G. A. Mostafa, R. M. El-Hossiny, S. I. Taha, and M. A. E. H. Ahamed. 2024. “Evaluation of Serum Interleukin-17 a and Interleukin-22 Levels in Pediatric Patients with Autism Spectrum Disorder: A Pilot Study.” BMC Pediatrics 24 (1): 18. https://doi.org/10.1186/s12887-023-04484-2.
  • Santocchi, E., L. Guiducci, M. Prosperi, S. Calderoni, M. Gaggini, F. Apicella, R. Tancredi, et al. 2020. “Effects of Probiotic Supplementation on Gastrointestinal, Sensory and Core Symptoms in Autism Spectrum Disorders: A Randomized Controlled Trial.” Frontiers in Psychiatry 11: 550593. https://doi.org/10.3389/fpsyt.2020.550593.
  • Saponaro, C., A. Cianciulli, R. Calvello, T. Dragone, F. Iacobazzi, and M. A. Panaro. 2012. “The PI3K/Akt Pathway is Required for LPS Activation of Microglial Cells.” Immunopharmacology and Immunotoxicology 34 (5): 858–865. https://doi.org/10.3109/08923973.2012.665461.
  • Schumann, C. M., S. C. Noctor, and D. G. Amaral. 2011. “Neuropathology of Autism Spectrum Disorders: Postmortem Studies.” In Autism Spectrum Disorders, edited by D. Amaral, D. Geschwind, and G. Dawson, 539–565. New York, NY: Oxford Academic.
  • Schwartzer, J. J., C. E. Onore, D. Rose, and P. Ashwood. 2017. “C57BL/6J Bone Marrow Transplant Increases Sociability in BTBR T + Itpr3tf/J Mice.” Brain, Behavior, and Immunity 59: 55–61. https://doi.org/10.1016/j.bbi.2016.05.019.
  • Sharifzadeh, N., A. Ghasemi, J. Tavakol Afshari, F. Moharari, A. Soltanifar, A. Talaei, H. R. Pouryousof, M. Nahidi, M. R. Fayyazi Bordbar, and M. Ziaee. 2021. “Intrathecal Autologous Bone Marrow Stem Cell Therapy in Children with Autism: A Randomized Controlled Trial.” Asia-Pacific Psychiatry 13 (2): e12445. https://doi.org/10.1111/appy.12445.
  • Sharma, A., and S. Mehan. 2021. “Targeting PI3K-AKT/mTOR Signaling in the Prevention of Autism.” Neurochemistry International 147: 105067. https://doi.org/10.1016/j.neuint.2021.105067.
  • Sharma, P., P. Mesci, C. Carromeu, D. R. McClatchy, L. Schiapparelli, J. R. Yates, A. R. Muotri, and H. T. Cline. 2019. “Exosomes Regulate Neurogenesis and Circuit Assembly.” Proceedings of the National Academy of Sciences of the United States of America 116 (32): 16086–16094. https://doi.org/10.1073/pnas.1902513116.
  • Shastri, A., D. M. Bonifati, and U. Kishore. 2013. “Innate Immunity and Neuroinflammation.” Mediators of Inflammation 2013: 342931. https://doi.org/10.1155/2013/342931.
  • Shen, Y., Y. Li, L. Shi, M. Liu, R. Wu, K. Xia, F. Zhang, J. Ou, and J. Zhao. 2021. “Autism Spectrum Disorder and Severe Social Impairment Associated with Elevated Plasma Interleukin-8.” Pediatric Research 89 (3): 591–597. https://doi.org/10.1038/s41390-020-0910-x.
  • Shen, Y., J. Ou, M. Liu, L. Shi, Y. Li, L. Xiao, H. Dong, F. Zhang, K. Xia, and J. Zhao. 2016. “Altered Plasma Levels of Chemokines in Autism and Their Association with Social Behaviors.” Psychiatry Research 244: 300–305. https://doi.org/10.1016/j.psychres.2016.07.057.
  • Shi, L., S. H. Fatemi, R. W. Sidwell, and P. H. Patterson. 2003. “Maternal Influenza Infection Causes Marked Behavioral and Pharmacological Changes in the Offspring.” The Journal of Neuroscience 23 (1): 297–302. https://doi.org/10.1523/JNEUROSCI.23-01-00297.2003.
  • Shi, L., N. Tu, and P. H. Patterson. 2005. “Maternal Influenza Infection is Likely to Alter Fetal Brain Development Indirectly: The Virus is Not Detected in the Fetus.” International Journal of Developmental Neuroscience 23 (23): 299–305. https://doi.org/10.1016/j.ijdevneu.2004.05.005.
  • Singer, H. S., C. M. Morris, P. N. Williams, D. Y. Yoon, J. J. Hong, and A. W. Zimmerman. 2006. “Antibrain Antibodies in Children with Autism and Their Unaffected Siblings.” Journal of Neuroimmunology 178 (12): 149–155. https://doi.org/10.1016/j.jneuroim.2006.05.025.
  • Singh, V. K. 1996. “Plasma Increase of Interleukin-12 and Interferon-Gamma Pathological Significance in Autism.” Journal of Neuroimmunology 66 (12): 143–145. https://doi.org/10.1016/0165-5728(96)00014-8.
  • Solso, S., R. Xu, J. Proudfoot, D. J. Hagler, K. Campbell, V. Venkatraman, C. Carter Barnes, et al. 2016. “Diffusion Tensor Imaging Provides Evidence of Possible Axonal Overconnectivity in Frontal Lobes in Autism Spectrum Disorder Toddlers.” Biological Psychiatry 79 (8): 676–684. https://doi.org/10.1016/j.biopsych.2015.06.029.
  • Sometani, A., H. Kataoka, A. Nitta, H. Fukumitsu, H. Nomoto, and S. Furukawa. 2001. “Transforming Growth Factor-1 Enhances Expression of Brain-Derived Neurotrophic Factor and Its Receptor, TrkB, in Neurons Cultured from Rat Cerebral Cortex.” Journal of Neuroscience Research. 66 (3): 369–376.
  • Song, Y., C. Liu, and S. M. Finegold. 2004. “Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children.” Applied and Environmental Microbiology 70 (11): 6459–6465. https://doi.org/10.1128/AEM.70.11.6459-6465.2004.
  • Suzuki, K., H. Matsuzaki, K. Iwata, Y. Kameno, C. Shimmura, S. Kawai, Y. Yoshihara, et al. 2011. “Plasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum Disorders.” PLoS One 6 (5): e20470. https://doi.org/10.1371/journal.pone.0020470.
  • Sweeten, T. L., D. J. Posey, S. Shankar, and C. J. McDougle. 2004. “High Nitric Oxide Production in Autistic Disorder: A Possible Role for Interferon-γ.” Biological Psychiatry 55 (4): 434–437. https://doi.org/10.1016/j.biopsych.2003.09.001.
  • Tang, G., K. Gudsnuk, S. H. Kuo, M. L. Cotrina, G. Rosoklija, A. Sosunov, M. S. Sonders, et al. 2014. “Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits.” Neuron 83 (5): 1131–1143. https://doi.org/10.1016/j.neuron.2014.07.040.
  • Tavazoie, S. F., V. A. Alvarez, D. A. Ridenour, D. J. Kwiatkowski, and B. L. Sabatini. 2005. “Regulation of Neuronal Morphology and Function by the Tumor Suppressors Tsc1 and Tsc2.” Nature Neuroscience 8 (12): 1727–1734. https://doi.org/10.1038/nn1566.
  • Tetreault, N. A., A. Y. Hakeem, S. Jiang, B. A. Williams, E. Allman, B. J. Wold, and J. M. Allman. 2012. “Microglia in the Cerebral Cortex in Autism.” Journal of Autism and Developmental Disorders 42 (12): 2569–2584. https://doi.org/10.1007/s10803-012-1513-0.
  • Than, U. T. T., L. T. Nguyen, P. H. Nguyen, X. H. Nguyen, D. P. Trinh, D. H. Hoang, P. A. T. Nguyen, and V. D. Dang. 2023. “Inflammatory Mediators Drive Neuroinflammation in Autism Spectrum Disorder and Cerebral Palsy.” Scientific Reports 13 (1): 22587. https://doi.org/10.1038/s41598-023-49902-8.
  • Thomson, A. W., H. R. Turnquist, and G. Raimondi. 2009. “Immunoregulatory Functions of mTOR Inhibition.” Nature Reviews Immunology 9 (5): 324–337. https://doi.org/10.1038/nri2546.
  • Tong, L., G. Aleph Prieto, E. A. Kramár, E. D. Smith, D. H. Cribbs, G. Lynch, and C. W. Cotman. 2012. “Brain-Derived Neurotrophic Factor-Dependent Synaptic Plasticity Is Suppressed by Interleukin-1β via p38 Mitogen-Activated Protein Kinase.” Journal of Neuroscience 32 (49): 17714–17724.
  • Torrente, F., P. Ashwood, R. Day, N. Machado, R. I. Furlano, A. Anthony, S. E. Davies, et al. 2002. “Small Intestinal Enteropathy with Epithelial IgG and Complement Deposition in Children with Regressive Autism.” Molecular Psychiatry 7 (4): 375–382, 334. https://doi.org/10.1038/sj.mp.4001077.
  • Tostes, M. H. F. S., H. C. Teixeira, W. F. Gattaz, M. A. F. Brandão, and N. R. B. Raposo. 2012. “Altered Neurotrophin, Neuropeptide, Cytokines and Nitric Oxide Levels in Autism.” Pharmacopsychiatry 45 (6): 241–243. https://doi.org/10.1055/s-0032-1301914.
  • Trifonova, E. A., A. I. Klimenko, Z. S. Mustafin, S. A. Lashin, and A. V. Kochetov. 2021. “Do Autism Spectrum and Autoimmune Disorders Share Predisposition Gene Signature Due to Mtor Signaling Pathway Controlling Expression?” International Journal of Molecular Sciences 22 (10): 5248. https://doi.org/10.3390/ijms22105248.
  • Tsilioni, I., A. Taliou, K. Francis, and T. C. Theoharides. 2015. “Children with Autism Spectrum Disorders, Who Improved with a Luteolin-Containing Dietary Formulation, Show Reduced Serum Levels of TNF and IL-6.” Translational Psychiatry 5 (9): e647–e647. https://doi.org/10.1038/tp.2015.142.
  • Turner, M. D., B. Nedjai, T. Hurst, and D. J. Pennington. 2014. “Cytokines and Chemokines: At the Crossroads of Cell Signalling and Inflammatory Disease.” Biochimica et Biophysica Acta - Molecular Cell Research 1843 (11): 2563–2582.
  • Turvey, S. E., and D. H. Broide. 2010. “Innate Immunity.” Journal of Allergy and Clinical Immunology 125 (2): S24–S32. https://doi.org/10.1016/j.jaci.2009.07.016.
  • Vanhala, R., U. Turpeinen, and R. Riikonen. 2001. “Low Levels of Insulin-like Growth factor-I in Cerebrospinal Fluid in Children with Autism.” Developmental Medicine and Child Neurology 43 (9): 614–616. https://doi.org/10.1017/s0012162201001116.
  • Vargas, D. L., C. Nascimbene, C. Krishnan, A. W. Zimmerman, and C. A. Pardo. 2005. “Neuroglial Activation and Neuroinflammation in the Brain of Patients with Autism.” Annals of Neurology 57 (1): 67–81. https://doi.org/10.1002/ana.20315.
  • Walensky, R. P., R. Bunnell, C. K. Kent, A. J. Gottardy, M. A. Leahy, J. C. Martinroe, S. R. Spriggs, et al. 2020. “Morbidity and Mortality Weekly Report Prevalence and Characteristics of Autism Spectrum Disorder among Children Aged 8 Years-Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020 Surveillance Summaries Centers for Disease Control and Prevention MMWR Editorial and Production Staff (Serials) MMWR Editorial Board.”
  • Walker, S. J., J. Fortunato, L. G. Gonzalez, and A. Krigsman. 2013. “Identification of Unique Gene Expression Profile in Children with Regressive Autism Spectrum Disorder (ASD) and Ileocolitis.” PLoS One 8 (3): e58058. https://doi.org/10.1371/journal.pone.0058058.
  • Wang, J., Y. Yao, X. Chen, J. Wu, T. Gu, and X. Tang. 2018. “Host Derived Exosomes-Pathogens Interactions: Potential Functions of Exosomes in Pathogen Infection.” Biomedicine & Pharmacotherapy 108: 1451–1459. https://doi.org/10.1016/j.biopha.2018.09.174.
  • Wang, X., J. Yang, H. Zhang, J. Yu, and Z. Yao. 2019. “Oral Probiotic Administration during Pregnancy Prevents Autism-Related Behaviors in Offspring Induced by Maternal Immune Activation via Anti-Inflammation in Mice.” Autism Research 12 (4): 576–588. https://doi.org/10.1002/aur.2079.
  • Wegiel, J., I. Kuchna, K. Nowicki, H. Imaki, J. Wegiel, Y. S. Ma, E. C. Azmitia, et al. 2013. “Contribution of Olivofloccular Circuitry Developmental Defects to Atypical Gaze in Autism.” Brain Research 1512: 106–122. https://doi.org/10.1016/j.brainres.2013.03.037.
  • Wei, H., H. Zou, A. M. Sheikh, M. Malik, C. Dobkin, W. T. Brown, and X. Li. 2011. “IL-6 is Increased in the Cerebellum of Autistic Brain and Alters Neural Cell Adhesion, Migration and Synaptic Formation.” Journal of Neuroinflammation 8 (1): 52. https://doi.org/10.1186/1742-2094-8-52.
  • Whyte, E., D. Elbich, M. Behrmann, N. Minshew, and K. S. Scherf. 2015. “Altered Functional Connectivity in the Core and Extended Face-Processing Network in Adolescents with Autism.” Journal of Vision 15 (12): 1209. https://doi.org/10.1167/15.12.1209.
  • Wills, S., M. Cabanlit, J. Bennett, P. Ashwood, D. G. Amaral, and J. Van de Water. 2009. “Detection of Autoantibodies to Neural Cells of the Cerebellum in the Plasma of Subjects with Autism Spectrum Disorders.” Brain, Behavior, and Immunity 23 (1): 64–74. https://doi.org/10.1016/j.bbi.2008.07.007.
  • Wong, P. H., and K. M. White. 2016. “Impact of Immunoglobulin Therapy in Pediatric Disease: A Review of Immune Mechanisms.” Clinical Reviews in Allergy & Immunology 51 (3): 303–314. https://doi.org/10.1007/s12016-015-8499-2.
  • Wyman, B., and A. Perl. 2020. “Metabolic Pathways Mediate Pathogenesis and Offer Targets for Treatment in Rheumatic Diseases.” Current Opinion in Rheumatology 32 (2): 184–191. https://doi.org/10.1097/BOR.0000000000000687.
  • Xian, P., Y. Hei, R. Wang, T. Wang, J. Yang, J. Li, Z. Di, et al. 2019. “Mesenchymal Stem Cell-Derived Exosomes as a Nanotherapeutic Agent for Amelioration of Inflammation-Induced Astrocyte Alterations in Mice.” Theranostics 9 (20): 5956–5975. https://doi.org/10.7150/thno.33872.
  • Xie, L., G. R. Choudhury, A. Winters, S. H. Yang, and K. Jin. 2015. “Cerebral Regulatory T Cells Restrain Microglia/Macrophage-Mediated Inflammatory Responses via IL-10.” European Journal of Immunology 45 (1): 180–191. https://doi.org/10.1002/eji.201444823.
  • Xu, G., J. Jing, K. Bowers, B. Liu, and W. Bao. 2014. “Maternal Diabetes and the Risk of Autism Spectrum Disorders in the Offspring: A Systematic Review and Meta-Analysis.” Journal of Autism and Developmental Disorders 44 (4): 766–775. https://doi.org/10.1007/s10803-013-1928-2.
  • Yang, X. O., A. D. Panopoulos, R. Nurieva, S. H. Chang, D. Wang, S. S. Watowich, and C. Dong. 2007. “STAT3 Regulates Cytokine-Mediated Generation of Inflammatory Helper T Cells.” Journal of Biological Chemistry 282 (13): 9358–9363. https://doi.org/10.1074/jbc.C600321200.
  • Young, A. M. H., E. Campbell, S. Lynch, J. Suckling, and S. J. Powis. 2011. “Aberrant NF-kappaB Expression in Autism Spectrum Condition: A Mechanism for Neuroinflammation.” Frontiers in Psychiatry 2: 27. https://doi.org/10.3389/fpsyt.2011.00027.
  • Zeng, H., and H. Chi. 2014. “mTOR Signaling and Transcriptional Regulation in T Lymphocytes.” Transcription 5 (2): e28263. https://doi.org/10.4161/trns.28263.
  • Zerbo, O., Y. Qian, C. Yoshida, J. K. Grether, J. Van de Water, and L. A. Croen. 2015. “Maternal Infection during Pregnancy and Autism Spectrum Disorders.” Journal of Autism and Developmental Disorders 45 (12): 4015–4025. https://doi.org/10.1007/s10803-013-2016-3.
  • Zerbo, O., C. Yoshida, J. K. Grether, J. Van de Water, P. Ashwood, G. N. Delorenze, R. L. Hansen, M. Kharrazi, and L. A. Croen. 2014. “Neonatal Cytokines and Chemokines and Risk of Autism Spectrum Disorder: The Early Markers for Autism (EMA) Study: A Case-Control Study.” Journal of Neuroinflammation 11 (1): 113. https://doi.org/10.1186/1742-2094-11-113.
  • Zhang, Y. D., Z. Chen, Y. Q. Song, C. Liu, and Y. P. Chen. 2005. “Making a Tooth: Growth Factors, Transcription Factors, and Stem Cells.” Cell Research 15 (5): 301–316. https://doi.org/10.1038/sj.cr.7290299.
  • Zhao, H., H. Zhang, S. Liu, W. Luo, Y. Jiang, and J. Gao. 2021. “Association of Peripheral Blood Levels of Cytokines with Autism Spectrum Disorder: A Meta-Analysis.” Frontiers in Psychiatry 12: 670200. https://doi.org/10.3389/fpsyt.2021.670200.
  • Zhou, J., J. Blundell, S. Ogawa, C. H. Kwon, W. Zhang, C. Sinton, C. M. Powell, and L. F. Parada. 2009. “Pharmacological Inhibition of mTORCl Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific PTEN Knock-out Mice.” Journal of Neuroscience 29 (6): 1773–1783.
  • Zhou, L., M. M. W. Chong, and D. R. Littman. 2009. “Plasticity of CD4+ T Cell Lineage Differentiation.” Immunity 30 (5): 646–655. https://doi.org/10.1016/j.immuni.2009.05.001.
  • Zhou, L. J., T. Yang, X. Wei, Y. Liu, W. J. Xin, Y. Chen, R. P. Pang, Y. Zang, Y. Y. Li, and X. G. Liu. 2011. “Brain-Derived Neurotrophic Factor Contributes to Spinal Long-Term Potentiation and Mechanical Hypersensitivity by Activation of Spinal Microglia in Rat.” Brain, Behavior, and Immunity 25 (2): 322–334. https://doi.org/10.1016/j.bbi.2010.09.025.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.